MlLabs.co.uk
Title
Innovata plc
Description
Company Profile
Innovata plc specialises in the development of pulmonary products for the treatment of respiratory disorders and other serious diseases. Using its proprietary dry powder inhaler and drug formulation technologies, the company has developed a pipeline of revenue-generating/marketed and clinical-stage products. In addition, the company has a portfolio of non-pulmonary products with growing revenues. Innovata has established development and marketing partnerships with a number of pharmaceutical companies including Baxter, Merck KGaA , UCB and Otsuka.
Innovata was formed in July 2005 when ML Laboratories PLC acquired Quadrant Technologies Limited and the remaining minority interest in Innovata Biomed Limited. The company has over 90 employees of whom 65 are engaged in research and development, mainly based at Innovata plc’s headquarters in Ruddington, Nottingham, United Kingdom.
